VSIR and neoplasm: Consistent with the public scRNA-seq data of CRC, FACS analysis in this study revealed that tumor cell-specific expression of VISTA was positive in all CRC tissues, with VISTA-positive CRC cells ranging from 15.7 to 36.8%, suggesting that VISTA is indeed expressed in tumor cells.